Back to News
Market Impact: 0.4
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
J&J shares fell 5.8% despite an earnings beat and raised guidance. MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
JNJ-0.35
More News
- Jim Cramer says this healthcare stock is still a buy. Plus, what to do with BNY
- Why is Samsung Electronics stock plunging today?
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- Why is Rocket Lab stock tumbling today?
- US Stocks Tumble as Chip Rout Deepens